First Time Loading...

ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 67.11 USD 0.89% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one ANIP stock under the Base Case scenario is 101.32 USD. Compared to the current market price of 67.11 USD, ANI Pharmaceuticals Inc is Undervalued by 34%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ANIP Relative Value
Base Case
101.32 USD
Undervaluation 34%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
28
vs Industry
42
Median 3Y
2.4
Median 5Y
2.4
Industry
2.4
Forward
2.5
More Details
88.8
P/E
P/E
Price to Earnings
88.8
vs History
12
vs Industry
4
Median 3Y
-14.5
Median 5Y
-14.2
Industry
22.9
Forward
14.4
More Details
11.6
P/OCF
P/OCF
Price to OCF
11.6
vs History
66
vs Industry
33
Median 3Y
12.7
Median 5Y
13.8
Industry
17.1
More Details
17.8
P/FCFE
P/FCFE
Price to FCFE
17.8
vs History
63
vs Industry
24
Median 3Y
18.9
Median 5Y
24.1
Industry
23.2
More Details
3
P/B
P/B
Price to Book Value
3
vs History
23
vs Industry
27
Median 3Y
2.3
Median 5Y
2.3
Industry
2.1
More Details
3
EV/S
EV/S
Enterprise Value to Sales
3
vs History
55
vs Industry
39
Median 3Y
3
Median 5Y
3
Industry
2.6
Forward
2.6
More Details
4.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.7
vs History
61
vs Industry
45
Median 3Y
5
Median 5Y
4.9
Industry
5.1
More Details
13.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.3
vs History
42
vs Industry
29
Median 3Y
14.6
Median 5Y
13.2
Industry
13.6
Forward
10.1
More Details
29.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29.9
vs History
33
vs Industry
15
Median 3Y
25.1
Median 5Y
25.4
Industry
17
Forward
10
More Details
12.1
EV/OCF
EV/OCF
Enterprise Value to OCF
12.1
vs History
68
vs Industry
33
Median 3Y
16.7
Median 5Y
16.7
Industry
15.8
More Details
13.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
13.1
vs History
63
vs Industry
26
Median 3Y
13.1
Median 5Y
17.8
Industry
17.6
More Details
2.2
EV/IC
EV/IC
Enterprise Value to IC
2.2
vs History
17
vs Industry
35
Median 3Y
1.4
Median 5Y
1.4
Industry
1.9
More Details

Multiples Across Competitors

ANIP Competitors Multiples
ANI Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
ANI Pharmaceuticals Inc
NASDAQ:ANIP
1.4B USD 2.8 88.8 13.3 29.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
717.6B USD 21 136.9 61.8 71
DK
Novo Nordisk A/S
CSE:NOVO B
3.9T DKK 16.8 46.5 34 37.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
360.9B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
324.7B USD 5.3 140.8 33.5 53.1
UK
AstraZeneca PLC
LSE:AZN
188.4B GBP 5.2 39.7 140.8 225.8
CH
Novartis AG
SIX:NOVN
181.7B CHF 4.3 13.4 9.8 16.3
CH
Roche Holding AG
SIX:ROG
170.7B CHF 2.9 14.8 8.5 10.1
US
Pfizer Inc
NYSE:PFE
156.4B USD 2.7 73.8 11 16.3

See Also

Summary
ANIP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ANIP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ANIP stock valuation using valuation multiples.
Wall Street Estimates
ANIP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ANIP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.